Syncope and Transient Loss of Consciousness: Multidisciplinary Management

Preface.

Part 1 Syncope and TLOC overview.

1 Definition and classification of syncope and transient.

loss of consciousness.

Jean-Jacques Blanc.

2 Epidemiologic aspects of transient loss of consciousness/syncope.

Robert S Sheldon, Anna Serletis.

3 Pathophysiology of syncope: postural, neurally-mediated,.

and arrhythmic.

W Wieling.

4 Cerebral perfusion in syncope.

J Gert van Dijk, Roland D Thijs.

5 Risk stratification—impact on diagnostic strategy.

Brian Olshansky.

Part 2 Clinical evaluation strategies.

6 Value and limitations of clinical history in assessing cause of syncope.

Paolo Alboni, Maurizio Dinelli.

7 Emergency department evaluation of transient loss of consciousness/.

syncope.

Franc¸ois P Sarasin.

8 The essential autonomic assessment for evaluating the.

cause of syncope.

Carlos A Morillo, Juan C Guzman.

9 Neurally-mediated reflex syncope: recognition by history and.

clinical testing.

Anna Serletis, Robert S Sheldon.

10 Value and limitations of ambulatory electrocardiographic monitoring.

Andrew D Krahn.

11 Recording ambulatory blood pressure in the syncope and.

TLOC evaluation.

Dietrich Andresen.

12 Electrophysiologic testing: value and limitations in the transient loss of.

consciousness/syncope evaluation.

Suneet Mittal.

13 Intolerance to upright posture in autonomic failure and the postural.

tachycardia syndrome: assessment and treatment strategies.

Christopher J Mathias.

14 Improving tolerance to upright posture: current status of tilt-training.

and other physical maneuvers.

Hugo Ector, Tony Reybrouck.

15 Syncope in patients with bundle-branch block and other conduction.

system abnormalities.

Angel Moya.

Part 3 Specific conditions.

16 Treatment strategies in neurally-mediated reflex syncope: effectiveness of.

drugs, pacing, and physical maneuvers.

Richard Sutton.

17 Structural heart disease, syncope, and risk of sudden death: selection of.

patients for implantable cardioverter-defibrillator therapy.

Kathy L Lee, Hung-Fat Tse, Chu-Pak Lau.

18 Channelopathies as a cause of syncope.

T Boussy, Pedro Brugada.

19 Distinguishing seizures and pseudosyncope from syncope.

Adam P Fitzpatrick.

20 Syncope and transient loss of consciousness in children and adolescents:.

congenital and acquired conditions.

Hugh Calkins.

21 Transient loss of consciousness, syncope, and falls in the elderly.

Rose Anne Kenny.

22 Drug-induced (iatrogenic) syncope.

Gerald V Naccarelli.

Part 4 Economic and research aspects.

23 Syncope and the competitive athlete: recommendations for evaluation.

and permission to compete.

Franco Giada, Antonio Raviele (Ospedale Umberto I).

24 Role of syncope management units.

Win K Shen, Michele Brignole (Ospedali del Tigullio).

25 The impact of syncope and transient loss of consciousness on.

quality of life.

Blair P Grubb.

Part 5 Current controversies and future directions.

26 Driving and flying restrictions for the syncope and/or implanted.

cardiac device patient.

Christina M Murray, Dwight W Reynolds.

27 Clinical trials landscape: what’s new, what’s ongoing, what do.

we need.

Michele Brignole (Ospedali del Tigullio), David G Benditt (University of Minnesota Medical School), Wouter Wieling (Academic Medical Centre).

28 Syncope and transient loss of consciousness: multidisciplinary.

management.

A John Camm.

29 Syncope practice guidelines initiative.

David G Benditt (University of Minnesota Medical School).

Appendix: syncope consortium members.

Index